These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

600 related articles for article (PubMed ID: 26626081)

  • 41. Motor deficits associated with Huntington's disease occur in the absence of striatal degeneration in BACHD transgenic mice.
    Mantovani S; Gordon R; Li R; Christie DC; Kumar V; Woodruff TM
    Hum Mol Genet; 2016 May; 25(9):1780-91. PubMed ID: 26908618
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alterations in striatal synaptic transmission are consistent across genetic mouse models of Huntington's disease.
    Cummings DM; Cepeda C; Levine MS
    ASN Neuro; 2010 Jun; 2(3):e00036. PubMed ID: 20585470
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Functional interactions within striatal microcircuit in animal models of Huntington's disease.
    Ghiglieri V; Bagetta V; Calabresi P; Picconi B
    Neuroscience; 2012 Jun; 211():165-84. PubMed ID: 21756979
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synaptic RTP801 contributes to motor-learning dysfunction in Huntington's disease.
    Martín-Flores N; Pérez-Sisqués L; Creus-Muncunill J; Masana M; Ginés S; Alberch J; Pérez-Navarro E; Malagelada C
    Cell Death Dis; 2020 Jul; 11(7):569. PubMed ID: 32732871
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cell-Autonomous and Non-cell-Autonomous Pathogenic Mechanisms in Huntington's Disease: Insights from In Vitro and In Vivo Models.
    Creus-Muncunill J; Ehrlich ME
    Neurotherapeutics; 2019 Oct; 16(4):957-978. PubMed ID: 31529216
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hypothalamic expression of mutant huntingtin contributes to the development of depressive-like behavior in the BAC transgenic mouse model of Huntington's disease.
    Hult Lundh S; Nilsson N; Soylu R; Kirik D; Petersén Å
    Hum Mol Genet; 2013 Sep; 22(17):3485-97. PubMed ID: 23697793
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Localized changes to glycogen synthase kinase-3 and collapsin response mediator protein-2 in the Huntington's disease affected brain.
    Lim NK; Hung LW; Pang TY; Mclean CA; Liddell JR; Hilton JB; Li QX; White AR; Hannan AJ; Crouch PJ
    Hum Mol Genet; 2014 Aug; 23(15):4051-63. PubMed ID: 24634145
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pathological gamma oscillations, impaired dopamine release, synapse loss and reduced dynamic range of unitary glutamatergic synaptic transmission in the striatum of hypokinetic Q175 Huntington mice.
    Rothe T; Deliano M; Wójtowicz AM; Dvorzhak A; Harnack D; Paul S; Vagner T; Melnick I; Stark H; Grantyn R
    Neuroscience; 2015 Dec; 311():519-38. PubMed ID: 26546830
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Non-Cell Autonomous and Epigenetic Mechanisms of Huntington's Disease.
    Kim C; Yousefian-Jazi A; Choi SH; Chang I; Lee J; Ryu H
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830381
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cellular Analysis of Silencing the Huntington's Disease Gene Using AAV9 Mediated Delivery of Artificial Micro RNA into the Striatum of Q140/Q140 Mice.
    Keeler AM; Sapp E; Chase K; Sottosanti E; Danielson E; Pfister E; Stoica L; DiFiglia M; Aronin N; Sena-Esteves M
    J Huntingtons Dis; 2016 Oct; 5(3):239-248. PubMed ID: 27689620
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Selective Vulnerability of Striatal D2 versus D1 Dopamine Receptor-Expressing Medium Spiny Neurons in HIV-1 Tat Transgenic Male Mice.
    Schier CJ; Marks WD; Paris JJ; Barbour AJ; McLane VD; Maragos WF; McQuiston AR; Knapp PE; Hauser KF
    J Neurosci; 2017 Jun; 37(23):5758-5769. PubMed ID: 28473642
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reduced striatal acetylcholine efflux in the R6/2 mouse model of Huntington's disease: an examination of the role of altered inhibitory and excitatory mechanisms.
    Farrar AM; Callahan JW; Abercrombie ED
    Exp Neurol; 2011 Dec; 232(2):119-25. PubMed ID: 21864528
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Single nuclei RNA-seq reveals a medium spiny neuron glutamate excitotoxicity signature prior to the onset of neuronal death in an ovine Huntington's disease model.
    Jiang A; You L; Handley RR; Hawkins V; Reid SJ; Jacobsen JC; Patassini S; Rudiger SR; Mclaughlan CJ; Kelly JM; Verma PJ; Bawden CS; Gusella JF; MacDonald ME; Waldvogel HJ; Faull RLM; Lehnert K; Snell RG
    Hum Mol Genet; 2024 Aug; 33(17):1524-1539. PubMed ID: 38776957
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recurrent collateral connections of striatal medium spiny neurons are disrupted in models of Parkinson's disease.
    Taverna S; Ilijic E; Surmeier DJ
    J Neurosci; 2008 May; 28(21):5504-12. PubMed ID: 18495884
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nature and cause of mitochondrial dysfunction in Huntington's disease: focusing on huntingtin and the striatum.
    Oliveira JM
    J Neurochem; 2010 Jul; 114(1):1-12. PubMed ID: 20403078
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Downregulation of glial genes involved in synaptic function mitigates Huntington's disease pathogenesis.
    Onur TS; Laitman A; Zhao H; Keyho R; Kim H; Wang J; Mair M; Wang H; Li L; Perez A; de Haro M; Wan YW; Allen G; Lu B; Al-Ramahi I; Liu Z; Botas J
    Elife; 2021 Apr; 10():. PubMed ID: 33871358
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington's disease.
    Laforet GA; Sapp E; Chase K; McIntyre C; Boyce FM; Campbell M; Cadigan BA; Warzecki L; Tagle DA; Reddy PH; Cepeda C; Calvert CR; Jokel ES; Klapstein GJ; Ariano MA; Levine MS; DiFiglia M; Aronin N
    J Neurosci; 2001 Dec; 21(23):9112-23. PubMed ID: 11717344
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Single-Nucleus RNA-Seq Reveals Dysregulation of Striatal Cell Identity Due to Huntington's Disease Mutations.
    Malaiya S; Cortes-Gutierrez M; Herb BR; Coffey SR; Legg SRW; Cantle JP; Colantuoni C; Carroll JB; Ament SA
    J Neurosci; 2021 Jun; 41(25):5534-5552. PubMed ID: 34011527
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Microglial physiological properties and interactions with synapses are altered at presymptomatic stages in a mouse model of Huntington's disease pathology.
    Savage JC; St-Pierre MK; Carrier M; El Hajj H; Novak SW; Sanchez MG; Cicchetti F; Tremblay MÈ
    J Neuroinflammation; 2020 Apr; 17(1):98. PubMed ID: 32241286
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of Exogenous NUB1 Expression in the Striatum of HDQ175/Q7 Mice.
    Vodicka P; Chase K; Iuliano M; Valentine DT; Sapp E; Lu B; Kegel-Gleason KB; Sena-Esteves M; Aronin N; DiFiglia M
    J Huntingtons Dis; 2016 Jun; 5(2):163-74. PubMed ID: 27314618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.